Subscribe to Updates in Healthcare

RSS By Email

RSS By RSS

Add to Google Reader or Homepage

Subscribe in Bloglines


The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

Study Group: Physicians who Treat RLS (US)(?)

Council Members in this Study Group: 84

This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.

Request a survey with this Study Group







Leading Experts in this Study Group

Daniel Wynn, MD, Director, Clinical Research, Consultants In Neurology Ltd.Daniel Wynn, MD
Director, Clinical Research
Consultants In Neurology Ltd.

Daniel Wynn, MD, FACN, FAASM, is a Director of Clinical Research at Consultants in Neurology in Chicago, Illinois. He has expertise in a wide variety of neurological illnesses and has served as a principal investigator in over 100 clinical trials in multiple sclerosis, Alzheimer's disease, stroke, chronic...

Walter Carlini, MD, PhD
Neurologist
Medford Neurological Clinic, Inc.

Walter Carlini, MD, PhD, is a General Neurologist at Medford Neurological Clinic in Oregon. His clinical interests include stroke, epilepsy, migraine, dementia, movement disorders, and multiple sclerosis. Dr. Carlini has expertise in clinical neurophysiology and in the use of botulinum toxin injections...

Warren Botnick, MD
President
PSS Clinical Research

Warren Botnick, MD, FCCP, DABSM, is a Partner at Pulmonary and Sleep Specialists in Decatur, Georgia, since March 2003. He is Director of Critical Care Unit and Chief of Medicine at DeKalb Medical Center, Medical Director of Southern Sleep Technologies, and Co-Director of two sleep disorders centers...

James Marquardt, RCP, PSGT
Chief Executive Officer/Owner
Marin Diagnostics Inc.

James Marquardt, RCP, PSGT, is the Chief Executive Officer of Marin Diagnostics, Inc. His corporation includes multiple sleep laboratories and CPAP and BiPAP companies in California. Mr. Marquardt also has expertise in the growth of the CPAP and sleep business as well as the financial aspects of running...

John Litton Jr., MD, Chief Executive Officer and President, Litton Family Medicine, PCJohn Litton Jr., MD
Chief Executive Officer and President
Litton Family Medicine, PC

J. Scott Litton, Jr., MD, FAAFP, is the Chief Executive Officer and President of Litton Family Medicine, PC in Pennington Gap, VA. He provides inpatient services and also serves as the Medical Director of the Center for Wound Care at Lee Regional Medical Center. Dr. Litton serves as a Faculty member...

Luc Jasmin, MD, PhD
Attending Neurosurgeon and a Research Scientist
Cedars-Sinai Medical Center

Luc Jasmin, MD, PhD, is an Attending Neurosurgeon and Research Scientist at Cedars Sinai Medical Center in Los Angeles. Dr. Jasmin is involved in a surgical practice and research centered on the treatment of pain and spinal disorders. His clinical work includes cancer spinal surgery as well as treating...

GLG NewsSMAnalyses by this Study Group's Leading Experts(?)

Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
"Tamper-Proof" -- A Significant Gain to Whom?? | 11-17-2008
Analysis of: FDA Asks if Pain Pill Is Tamper-Proof | online.wsj.com
Author: Daniel Wynn, MD, Director, Clinical Research, Consultants In Neurology Ltd.

Abuse resistant long acting narcotics offer benefit as they are less desirable to those who might wish a quick high via snorting, injecting crushed time-release narcotic. Unfortunately, given the higher cost than long acting generics and increased pressure on physicians to prescribe generics, expect...

Doctors don't profit from EHRs | 06-23-2008
Author: GLG Expert Contributor

Third party payers benefit the most from EHRs because it makes charts easier to audit   The cost of implementing an EHR is excessive for a small practice of 2-5 physicians.

Novartis and Multiple Sclerosis: A Major Commitment | 06-05-2008
Author: Daniel Wynn, MD, Director, Clinical Research, Consultants In Neurology Ltd.

Extavia, Novartis' brand of  interferon beta 1b, has been approved for the  treatment of multiple sclerosis by the European Union.  With FTY72, Fingolimod, Novartis has the eye on filing NDA by the end of 2009.  While essentially identical to Bayer's Betaferon interferon beta 1b,...

Abbott's ABT-089 --Much More than a Treatment for ADHD | 06-02-2008
Author: Daniel Wynn, MD, Director, Clinical Research, Consultants In Neurology Ltd.

The data on ABT-089 in adults has been released with positive results, whereas the adolescent/childhood trial is on-going for this novel compound for ADHD.  The key difference is the potential to improve learning, not simply regain attention and lessen hyperactivity.

COPAXONE from the START of MS | 04-24-2008
Author: Daniel Wynn, MD, Director, Clinical Research, Consultants In Neurology Ltd.

Copaxone has become the leading treatment for relapsing remitting MS in the US.  The results of the PRECISE trial will likely add to TEVA's sales momentum and boost sales further.

View All GLG News by members of this Study Group

Most Common Company Types:

  • Academic Medical Center/Hospital or Clinic
  • Office Based Private Practice or Clinic
  • Non-Academic Community Hospital or Clinic
  • Hospice Facility
  • Laboratory, Independent
  • Other Freestanding Healthcare Facility

Most Common Job Types:

  • Physician - Attending Physician
  • Physician - Director
  • Owner
  • President
  • Partner
  • Medical Director
  • Chief Executive Officer
  • Director

GLG's 750+ Clients Include:

40 of the leading 50
global mutual funds
15 of the leading 20
global banks
8 of the leading 10
private equity firms
90%+ client subscription renewal rate

Analytics


Generated at 2008-12-03T13:45:45.387